Spalinger, M., Hai, R., Li, J., Nordgren, T. M., Tremblay, M. L., Eckmann, L., . . . McCole, D. F. (2021). Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB. Gastroenterology.
Chicago-стиль цитированияSpalinger, Marianne, et al. "Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB." Gastroenterology 2021.
MLA-цитированиеSpalinger, Marianne, et al. "Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB." Gastroenterology 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.